Daily Newsletter

02 August 2023

Daily Newsletter

02 August 2023

Imeka’s ANDI imaging software receives FDA clearance

The software processes diffusion-weighted images for mapping microstructural properties of the white matter.

RanjithKumar Dharma August 01 2023

Imeka has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Advanced Neuro Diagnostic Imaging (ANDI) quantitative imaging software.

The ANDI-generated report offers crucial reference information on brain white matter to medical professionals, including neurologists and radiologists.

This software enables the extraction of white matter bundles, which link specific regions of the brain and perform microstructure analysis along these connections.

Imeka co-founder and scientific advisor Maxime Descoteaux said: “Imeka has spent the past 12 years developing novel neuroimaging technologies that play an influential role in the search for and development of cures for brain diseases.”

Leveraging modelling, tractography and fibre bundling algorithms, the device processes diffusion-weighted images for mapping microstructural properties of the white matter.

A DICOM-encapsulated PDF report will be generated by ANDI, focusing on bundles that exhibit a significant deviation from the normative range.

The report also provides a detailed analysis of the microstructural and macrostructural values of all bundles.

Imeka CEO Jean-René Bélanger said: “We are pleased to announce FDA 510(k) clearance of ANDI, our quantitative imaging software and make the technology available to healthcare providers across the US – which is going to have a major impact on brain disease management in the coming years.

“This also comes at a very crucial time with the announcement of the addition of two new CPT 3 codes by the AMA for quantitative brain MRI assessment, which we expect our clients to be able to get reimbursement from, starting in January 2024.”

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close